GAA (alpha glucosidase)

2014-11-01  

Identity

HGNC
LOCATION
17q25.3
LOCUSID
ALIAS
LYAG
FUSION GENES

Other Information

Locus ID:

NCBI: 2548
MIM: 606800
HGNC: 4065
Ensembl: ENSG00000171298

Variants:

dbSNP: 2548
ClinVar: 2548
TCGA: ENSG00000171298
COSMIC: GAA

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000171298ENST00000302262P10253
ENSG00000171298ENST00000390015P10253
ENSG00000171298ENST00000570803I3L3L3
ENSG00000171298ENST00000572080I3L2V9
ENSG00000171298ENST00000577106I3L0S5

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Galactose metabolismKEGGko00052
Starch and sucrose metabolismKEGGko00500
Galactose metabolismKEGGhsa00052
Starch and sucrose metabolismKEGGhsa00500
LysosomeKEGGko04142
LysosomeKEGGhsa04142
Metabolic pathwaysKEGGhsa01100
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
MetabolismREACTOMER-HSA-1430728
Metabolism of carbohydratesREACTOMER-HSA-71387
Glucose metabolismREACTOMER-HSA-70326
Glycogen breakdown (glycogenolysis)REACTOMER-HSA-70221
Lysosomal glycogen catabolismREACTOMER-HSA-5357572
Neutrophil degranulationREACTOMER-HSA-6798695

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
386142902024Human fecal alpha-glucosidase activity and its relationship with gut microbiota profiles and early stages of intestinal mucosa damage.0
386142902024Human fecal alpha-glucosidase activity and its relationship with gut microbiota profiles and early stages of intestinal mucosa damage.0
368050832023Phase I study of liver depot gene therapy in late-onset Pompe disease.6
374702822023Natural History and Phenotypic Spectrum of GAA-FGF14 Sporadic Late-Onset Cerebellar Ataxia (SCA27B).10
375422772023Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants.1
368050832023Phase I study of liver depot gene therapy in late-onset Pompe disease.6
374702822023Natural History and Phenotypic Spectrum of GAA-FGF14 Sporadic Late-Onset Cerebellar Ataxia (SCA27B).10
375422772023Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants.1
345300852022Genetic analysis of 76 Spanish Pompe disease patients: Identification of 12 novel pathogenic GAA variants and functional characterization of splicing variants.1
348646812022Late Onset Pompe Disease with Novel Mutations and Atypical Phenotypes.2
365176542022CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease.3
345300852022Genetic analysis of 76 Spanish Pompe disease patients: Identification of 12 novel pathogenic GAA variants and functional characterization of splicing variants.1
348646812022Late Onset Pompe Disease with Novel Mutations and Atypical Phenotypes.2
365176542022CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease.3
327182192021In silico assessment of potential leads identified from Bauhinia rufescens Lam. as α-glucosidase and α-amylase inhibitors.4

Citation

Dessen P

GAA (alpha glucosidase)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/63640